Clinical trial

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

NCT06596915

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention BA1302 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-11

PhasePHASE1

Conditions

Non-Small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Pancreatic Adenocarcinomaverified · MONDO: pancreatic adenocarcinoma

Breast Cancerverified · MONDO: breast cancer

Melanomaverified · MONDO: melanoma

Interventions

BA1302DRUG

Sponsors & collaborators

Shandong Boan Biotechnology Co., Ltdlead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06596915 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.